ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1430 National Cancer Institute Html en Stomach (Gastric) Cancer Prevention (PDQ®)–Patient Version Smoking and H. pylori infection are important risk factors for stomach (gastric) cancer. Learn about all of the risk factors for stomach cancer and how to prevent stomach cancer in this expert-reviewed summary.
PDQ Screening0.364501
cancer risk factors0.420087
cancer treatment0.365273
Cancer prevention0.532051
cancer prevention trials0.402318
healthy diet0.359621
cancer protective factor0.402244
United States0.45543
prevention clinical trials0.399973
protective factors0.416286
antibiotics lowers0.358249
following PDQ summaries0.402867
Cancer Information Service0.393528
PDQ cancer information0.513502
number0.358741
Clinical Trials section0.366407
common cancer0.369836
Prevention Editorial Board0.402679
treatment clinical trials0.365364
dietary supplements0.383267
H. pylori bacteria0.36065
National Cancer Institute0.462669
clinical trials0.512934
PDQ documents0.365522
beta carotene0.388269
health care0.357632
cancer information summary0.455266
cancer doctors0.360396
new treatment0.364974
breast cancer prevention0.387351
cancer patients0.36264
Cancer Care page0.385527
PDQ database0.368612
latest published information0.364412
cancer risk factor0.42115
NCI’s PDQ0.372914
PDQ summary0.382762
NCI PDQ cancer0.429445
cancer clinical trials0.401358
stomach cancer0.900678
risk factors0.486241
cancer information summaries0.399032
comprehensive cancer information0.399493
stomach cancer prevention0.492255
risk0.486594
CLICK HERE
1454 National Cancer Institute Html null Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Health Professional Version Mycosis fungoides and Sézary syndrome are neoplasias of malignant T lymphocytes that affect the skin. Learn about the clinical presentation, prognosis, staging, and treatment for mycosis fungoides and Sézary syndrome in this expert-reviewed summary.
CLICK HERE
1487 National Cancer Institute Html en Nasopharyngeal Cancer Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of nasopharyngeal cancer.
careful palpation0.292509
definitive phase0.242643
advanced nasopharyngeal carcinoma0.398201
skeletal metastases0.266633
neoadjuvant docetaxel0.519489
pituitary gland0.264361
chemotherapy group0.400142
intracranial spread.0.264667
advanced nasopharyngeal cancer.0.42411
cranial nerves0.273765
metastatic nodal involvement0.422787
skull base invasion0.38597
best possible estimate0.418099
pathologic data0.276646
clinical trials0.248887
entire thyroid gland0.381317
cisplatin0.267179
additional information0.256217
diagnostic imaging studies0.3903
nasopharyngeal carcinoma0.426393
Staging systems0.283956
clinical staging0.28075
tomographic scanning0.259213
combination chemotherapy0.398191
high incidence0.254716
Clin Oncol0.247874
fiberoptic endoscopic evaluation0.425036
neoadjuvant arm0.273047
3-year overall survival0.371579
metastatic spread0.269118
primary tumor0.430532
radiation treatment planning0.460358
drug combinations0.39538
definitive therapy0.394934
radiologic evaluation0.265134
Thyroid-function testing0.254938
neoadjuvant chemotherapy0.942422
randomized trials0.265028
control arm0.346677
Magnetic resonance imaging0.385943
disease-free survival0.258813
radiation therapy0.812458
retropharyngeal lymph nodes0.399429
target delineation0.255106
nodal drainage areas0.414589
Positron emission tomography0.391984
standard adjuvant therapy0.661523
CLICK HERE
1609 National Cancer Institute Html en Spirituality in Cancer Care (PDQ®)–Health Professional Version Expert-reviewed information summary about the influence of spirituality and religion on individuals who have cancer. Various approaches for management and intervention are discussed.
Illness Therapy—Spiritual Well-Being0.543912
religious involvement0.499717
Specific religious beliefs0.441508
religious beliefs0.523457
Functional Assessment0.445985
mental health0.442676
particular religious practices0.428153
religious well-being score0.469443
New York City0.462169
spiritual needs0.541346
overall spiritual well-being0.529919
spiritual coping0.434224
advanced cancer patients0.489002
apparent spiritual distress0.46645
religious community0.446225
health care professionals0.456817
greater religious involvement0.427553
breast cancer patients0.460344
patients0.767676
cancer patients0.691703
meaningful spiritual experiences0.440836
low spiritual well-being0.48099
acute spiritual distress0.458641
large national survey0.43272
spirituality0.547712
quality0.443662
lower levels0.487983
cancer survivors0.4658
Religious Coping Scale0.438267
study0.566426
religious well-being0.481178
high levels0.478978
life0.494023
spiritual struggle0.42918
spiritual well-being0.933157
Spiritual Concerns section0.456015
health care0.545672
spiritual concerns0.673861
advanced cancer0.607322
Spiritual Well-Being Scale0.489529
breast cancer0.638015
spiritual care0.428215
higher levels0.488544
prostate cancer0.443702
Chronic Illness Therapy—Spiritual0.506181
positive religious coping0.433202
religious coping methods0.47485
cancer0.779595
spiritual issues0.446953
CLICK HERE
1717 National Cancer Institute Html en Prostate-Specific Antigen (PSA) Test A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.
PSA test result0.530712
standard PSA test0.514168
prostate gland0.501515
yearly PSA screening0.54489
prostate cancer death0.513516
PSA testing0.531895
prostate portion0.48732
PSA velocity0.501342
prostate cancer treatment0.519577
single PSA test0.516116
PSA level0.830974
PSA levels0.535175
PSA tests0.519973
elevated PSA measurement0.513617
prostate health index0.490397
age-specific psa reference0.520098
single elevated PSA0.525104
false-positive test result0.465798
PSA level doubles0.514204
prostate cancer antigen0.506092
PSA test0.738071
annual prostate cancer0.514823
prostate cancers0.487259
prostate symptoms0.501281
PSA density0.497128
prostate biopsy0.543132
Cancer Screening Draft0.449679
prostate cancer deaths0.513742
PSA screening0.559657
high-grade prostate cancer0.507765
prostate cancer mortality0.517391
IsoPSA. PSA0.495429
early prostate cancer0.51777
man0.497168
free PSA0.51853
benign prostate conditions0.512878
prostate tissue0.490051
prostate cancer screening0.701845
prostate cancer0.931212
elevated PSA level0.615668
annual PSA test0.53093
optimal PSA threshold0.520019
prostate surgery0.493048
versus total PSA0.507136
et al0.454053
Prostate biopsies0.493435
Cancer Screening Trial0.453883
prostate cancer recurrence0.511015
CLICK HERE
1845 National Cancer Institute Html es Tratamiento del cáncer primario de hígado en adultos (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer primario de hígado en adultos.
percutaneous ethanol0.307629
Surg Oncol Clin0.302767
hepatocellular carcinoma based0.30936
hepatocellular carcinoma smaller0.309339
early hepatocellular carcinoma0.330465
quimioembolización arterial transcatéter0.307969
versus surgical resection0.303957
patients with cirrhosis0.308968
European patients with0.302703
with hepatocellular carcinoma0.310631
carcinoma among us0.306777
Bruix J0.308485
ethanol injection therapy0.303818
carcinoma with drug0.307102
hepatocellular carcinoma0.981778
BCLC staging classification0.303901
carcinoma using0.305993
small hepatocellular carcinoma0.369666
hepatocellular carcinoma after0.309033
estadificación tnm0.30443
patients with0.343761
radiofrequency ablation0.30759
retrospective study0.303001
Gastroenterol Hepatol0.306642
AASLD hepatocellular carcinoma0.309539
advanced hepatocellular carcinoma0.325377
sorafenib versus0.304969
untreated hepatocellular carcinoma0.309351
estadificación okuda0.306358
Lin CC0.303335
after percutaneous ethanol0.303796
recurrent hepatocellular carcinoma0.318564
estadificación bclc0.30882
Poon RT0.307702
controlled trial0.310604
Cancer Staging Manual0.303852
Radiofrequency ablation versus0.303706
Surg Oncol0.303137
aflatoxina b10.304027
Clin Oncol0.306158
Gastrointest Surg0.303366
carcinoma up0.306683
systematic review0.303509
Llovet JM0.316349
randomized controlled trial0.310237
Cardiovasc Intervent Radiol0.302772
cm hepatocellular carcinoma0.310978
American Joint Committee0.305624
prospective study0.30533
CLICK HERE
2008 National Cancer Institute Html es Tratamiento de los tumores de células germinativas del sistema nervioso central infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de los tumores de células germinativas del sistema nervioso central infantil.
células germinativas mixto0.606047
radiocirugía estereotáctica0.6031
siguientes procedimientos0.60241
células madre0.628533
efectos secundarios meses0.605521
siguientes especialistas0.601341
claro cuál0.600842
siguientes tipos0.602105
vía oral0.600964
células maduras0.607269
PDQ Descripción0.603561
largo plazo0.600917
efectos tardíos0.61368
PDQ Efectos tardíos0.603681
líquido cefalorraquídeo0.618915
punción espinal.Ampliar0.601432
National Cancer Institute0.601125
sustancia llamada gadolinio0.602465
células germinativas mixtas0.610091
siguientes riesgos0.600884
Instituto Nacional0.603777
PDQ Tratamiento0.609778
determinados cambios0.600765
Mucha sed0.601358
siguientes marcadores0.601725
saco vitelino0.603605
sistema nervioso central0.986252
Physician Data Query0.603955
Aboutâ„¢ Brain Tumors0.601381
ensayos clínicos.Terapia0.602108
tanta seguridad0.601228
siguientes enlaces0.600982
radiocirugía estereotáxica0.601123
CLICK HERE
3452 National Cancer Institute Html es Planificar la transición para la atención del cáncer avanzado en la etapa final de la vida (PDQ®)–Versión para pacientes Resumen de información revisada por expertos sobre la preparación necesaria por parte de los proveedores de atención de la salud, los pacientes y sus familias para la transición a la atención del cáncer avanzado en la etapa final de la vida.
etapa final0.993589
aspectos espirituales.Quimioterapia0.301674
PDQ Planificar0.301661
enfermedad progresa0.300844
Palliative Care Organization0.301866
Organización Nacional0.300803
Physician Data Query0.304167
Estados Unidos0.301443
practique reanimación cardiorrespiratoria0.304362
National Hospice0.300987
sección caring connections0.30178
siguientes consejos0.301301
cuánto tiempo0.301394
reanimación cardiorrespiratoria0.321909
familia hará frente0.30286
cuidados paliativos0.479509
National Cancer Institute0.301056
cuidado paliativo0.301307
siguientes riesgos0.300668
decisiones conjuntas0.304112
Instituto Nacional0.301868
CLICK HERE
3520 National Cancer Institute Html en Where Trials Take Place Information about the various settings in which cancer clinical trials take place.
NCI-designated cancer centers0.754234
veterans0.437829
clinics0.435881
United States0.797764
single trial0.604599
medical centers0.598598
offices0.436127
Cancer.gov clinical trials0.786399
world0.438646
NIH Clinical Center0.734388
clinical trials0.951404
place0.614988
hundreds0.437249
NCI network trials0.778802
cities0.438884
community hospitals0.619062
different sites0.602675
Cancer clinical trials0.789309
doctor0.455993
Canada0.433786
places0.435058
form0.434135
doctors0.439293
NCI-supported clinical trials0.74928
military hospitals0.617836
treatment options0.580271
towns0.446502
form.0.434179
CLICK HERE
16828 National Cancer Institute Html en Computational Genomics Research NCI’s Center for Cancer Genomics uses computational cancer genomics to derive insight about cancer genes and pathways using big data.
big datasets0.542777
genomic analysis0.686648
CCG data0.58375
HD video0.465732
computational approaches0.476443
independent submitters0.444997
Computational research0.470859
statistical models0.4439
analysis tools0.443955
single cell DNA0.563687
shares data0.501975
large genomic datasets0.997114
cancer driver mutations0.615431
file cabinets0.459486
Genomic Data Commons0.977931
clinical datasets0.540686
RNA expression0.456571
multiple genomic platforms0.828302
NCI’s Center0.447369
exceedingly complex relationships0.649797
Computational genomics research0.692909
multiple modes0.445152
cancer diagnostics0.487849
oncogenic pathways0.463218
computational techniques0.452264
Genomics Data Analysis0.678168
best ways0.449068
cancer genomic data0.909069
DNA sequence0.445849
expert programming0.466152
stores diverse datasets0.638138
complex datasets0.550815
cancer mechanisms0.478773
scalable cloud environment0.595936
unified view0.44922
Genome Characterization Pipeline0.557584
cancer researchers0.495463
RNA sequencing0.45187
democratize access0.474498
Cancer Genomics Cloud0.816717
Cancer Genome Atlas0.615653
cancer genomic databases0.9082
Genomics Cloud Pilots0.822542
robust genomic data0.825715
chromosomal copy number0.585632
NCI Genomic Data0.844471
exceedingly large number0.6264
new technologies0.445699
computationally-intensive genomic analyses0.756967
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.